Department of Histology and Embryology, Akdeniz University School of Medicine, 07070, Antalya, Turkey.
Department of Histology and Embryology, Ankara University School of Medicine, 06230, Ankara, Turkey.
J Assist Reprod Genet. 2020 Sep;37(9):2119-2136. doi: 10.1007/s10815-020-01875-7. Epub 2020 Jul 10.
We investigated whether expression of activator proteins that control follicle reserve and growth change after ovarian tissue vitrification and re-transplantation. Moreover, we assessed whether inhibition of mTOR signaling pathway by rapamycin would protect primordial follicle reserve after ovarian tissue freezing/thawing and re-transplantation.
Fresh control, frozen/thawed, fresh-transplanted, frozen/thawed and transplanted, rapamycin/control, rapamycin fresh-transplanted, and rapamycin frozen-thawed and transplanted groups were established in rats. After freezing and thawing process, two ovaries were transplanted into the back muscle of the same rat. After 2 weeks, grafts were harvested, fixed, and embedded into paraffin block. Normal and atretic primordial/growing follicle count was performed in all groups. Ovarian tissues were evaluated for the dynamic expressions of Gdf-9, Bmp-15, KitL, Lif, Fgf-2, and p-s6K using immunohistochemistry, and H-score analyses were done.
Primordial follicle reserve reduced almost 50% after ovarian tissue re-transplantation. Expression of Gdf-9 and Lif increased significantly in primordial and growing follicles in frozen-thawed, fresh-transplanted, and frozen/thawed and transplanted groups, whereas expression of Bmp-15, KitL, and Fgf-2 decreased in primordial follicles. Freezing and thawing of ovarian tissue solely significantly increased p-s6K expression in primordial follicles, and on the other hand, suppression of mTORC1 pathway using rapamycin preserved the primordial follicle pool.
Altered expressions of activator proteins that regulate primordial follicle reserve and growth may lead to primordial follicle loss and rapamycin treatment can protect ovarian reserve after ovarian tissue cryopreservation/transplantation.
我们研究了在卵巢组织玻璃化和再移植后,控制卵泡储备和生长的激活蛋白的表达是否会发生变化。此外,我们评估了雷帕霉素(mTOR 信号通路的抑制剂)是否会在卵巢组织冷冻/解冻和再移植后保护原始卵泡储备。
在大鼠中建立了新鲜对照组、冷冻/解冻组、新鲜移植组、冷冻/解冻和移植组、雷帕霉素/对照组、雷帕霉素新鲜移植组和雷帕霉素冷冻/解冻和移植组。冷冻和解冻过程后,将两个卵巢移植到同一只大鼠的背部肌肉中。2 周后,采集移植物,固定并嵌入石蜡块中。对所有组进行正常和闭锁原始/生长卵泡计数。使用免疫组织化学法评估卵巢组织中 Gdf-9、Bmp-15、KitL、Lif、Fgf-2 和 p-s6K 的动态表达,并进行 H 评分分析。
卵巢组织再移植后,原始卵泡储备减少了近 50%。冷冻/解冻、新鲜移植和冷冻/解冻和移植组中原始和生长卵泡的 Gdf-9 和 Lif 表达显著增加,而 Bmp-15、KitL 和 Fgf-2 的表达在原始卵泡中减少。卵巢组织的冷冻和解冻单独显著增加了原始卵泡中 p-s6K 的表达,而另一方面,使用雷帕霉素抑制 mTORC1 通路可以保护原始卵泡池。
调节原始卵泡储备和生长的激活蛋白表达的改变可能导致原始卵泡丢失,雷帕霉素治疗可以在卵巢组织冷冻/移植后保护卵巢储备。